Epigenomic profiling reveals DNA-methylation changes associated with major psychosis

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Epigenetic misregulation is implicated in non-Mendelian disorders like schizophrenia and bipolar disorder.
• Limited research exists on DNA methylation's role in major psychosis, with no prior genome-wide epigenomic studies.

Purpose of the Study:

• To identify DNA methylation changes in the frontal cortex and germline associated with schizophrenia and bipolar disorder using a genome-wide approach.
• To explore the functional implications of these epigenetic alterations in the context of major psychosis.

Main Methods:

• Utilized CpG-island microarrays for genome-wide DNA methylation analysis.
• Examined DNA methylation in frontal cortex and germline samples from individuals with schizophrenia and bipolar disorder.
• Performed gene-ontology and methylome network analyses to interpret findings.

Main Results:

• Identified numerous psychosis-associated DNA methylation differences in the frontal cortex, affecting genes involved in neurotransmission, brain development, and mitochondrial function.
• Observed decreased epigenetic modularity in both brain and germline, suggesting systemic epigenetic dysfunction.
• Found correlations between DNA methylation, antipsychotic use (MEK1 gene), and genetic variations (BDNF gene) in patients.

Conclusions:

• DNA methylation alterations are significantly associated with the etiology of schizophrenia and bipolar disorder.
• Systemic epigenetic dysfunction may underlie major psychosis.
• Epigenetic modifications represent a potential avenue for understanding and treating these complex psychiatric disorders.